Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (201-210 of 306) with videos related to

Pageof 31
Sort By:
Hepatology International|March 20, 2015
New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in JapanYusuke Kawamura, Kenji Ikeda, Yasuji Arase, et al.
Hepatology (Baltimore, Md.)|July 19, 2012
Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesisNorio Akuta, Fumitaka Suzuki, Yuya Seko, et al.
Journal of Medical Virology|May 27, 2003
HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis BFumitaka Suzuki, Akihito Tsubota, Yasuji Arase, et al.
Intervirology|July 8, 2011
Amino acid substitution in HCV core/NS5A region and genetic variation near IL28B gene affect treatment efficacy to interferon plus ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Intervirology|July 18, 2003
Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in JapanFumitaka Suzuki, Akihito Tsubota, Yasuji Arase, et al.
Journal of Gastroenterology and Hepatology|April 20, 2005
Virological differences between patients infected with subtypes Ba and Bj of hepatitis B virus genotype BMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Gastroenterology|November 19, 2004
Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in JapanFumitaka Suzuki, Yasuji Arase, Norio Akuta, et al.
Hepatology International|April 15, 2016
Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in JapanNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.
Journal of Medical Virology|September 15, 2017
Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1bNobuhiko Ogasawara, Masahiro Kobayashi, Norio Akuta, et al.
Journal of Gastroenterology|August 24, 2018
Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in JapanFumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, et al.
Pageof 31

Showing results (201-210 of 306) with videos related to

Sort By:
Pageof 31
Hepatology International|March 20, 2015
New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in JapanYusuke Kawamura, Kenji Ikeda, Yasuji Arase, et al.
Hepatology (Baltimore, Md.)|July 19, 2012
Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesisNorio Akuta, Fumitaka Suzuki, Yuya Seko, et al.
Journal of Medical Virology|May 27, 2003
HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis BFumitaka Suzuki, Akihito Tsubota, Yasuji Arase, et al.
Intervirology|July 8, 2011
Amino acid substitution in HCV core/NS5A region and genetic variation near IL28B gene affect treatment efficacy to interferon plus ribavirin combination therapyNorio Akuta, Fumitaka Suzuki, Miharu Hirakawa, et al.
Intervirology|July 18, 2003
Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in JapanFumitaka Suzuki, Akihito Tsubota, Yasuji Arase, et al.
Journal of Gastroenterology and Hepatology|April 20, 2005
Virological differences between patients infected with subtypes Ba and Bj of hepatitis B virus genotype BMariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Journal of Gastroenterology|November 19, 2004
Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in JapanFumitaka Suzuki, Yasuji Arase, Norio Akuta, et al.
Hepatology International|April 15, 2016
Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in JapanNorio Akuta, Yusuke Kawamura, Fumitaka Suzuki, et al.
Journal of Medical Virology|September 15, 2017
Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1bNobuhiko Ogasawara, Masahiro Kobayashi, Norio Akuta, et al.
Journal of Gastroenterology|August 24, 2018
Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in JapanFumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, et al.
Pageof 31